Compare Amphastar Pharmaceuticals Inc (AMPH) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Rocket Lab USA Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Rocket Lab USA Inc trades at $79.67 (market cap $50.01B). The key difference: Rocket Lab USA Inc is far larger — about 57.6× Amphastar Pharmaceuticals Inc's market cap, and Rocket Lab USA Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | RKLB | |
|---|---|---|
Market Cap | $868.62M | $50.01B |
Sector | Health | Technology |
52-Week High | $30.81 | $150.23 |
52-Week Low | $16.87 | $39.48 |
Enterprise Value | $1.27B | $47.84B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
